Peré Domingo

17.1k total citations
392 papers, 9.5k citations indexed

About

Peré Domingo is a scholar working on Infectious Diseases, Virology and Emergency Medicine. According to data from OpenAlex, Peré Domingo has authored 392 papers receiving a total of 9.5k indexed citations (citations by other indexed papers that have themselves been cited), including 238 papers in Infectious Diseases, 175 papers in Virology and 161 papers in Emergency Medicine. Recurrent topics in Peré Domingo's work include HIV/AIDS drug development and treatment (188 papers), HIV Research and Treatment (174 papers) and HIV-related health complications and treatments (161 papers). Peré Domingo is often cited by papers focused on HIV/AIDS drug development and treatment (188 papers), HIV Research and Treatment (174 papers) and HIV-related health complications and treatments (161 papers). Peré Domingo collaborates with scholars based in Spain, United States and United Kingdom. Peré Domingo's co-authors include Francesc Villarroya, Marta Giralt, Joan Carles Domingo, Bonaventura Clotet, Estebán Martínez, Esteban Ribera, José M. Gallego‐Escuredo, Guillermo Vázquez, Francesc Vidal and Josep M. Llibre and has published in prestigious journals such as New England Journal of Medicine, The Lancet and JAMA.

In The Last Decade

Peré Domingo

379 papers receiving 9.2k citations

Peers

Countries citing papers authored by Peré Domingo

Since Specialization

Citations

This map shows the geographic impact of Peré Domingo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peré Domingo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peré Domingo more than expected).

Fields of papers citing papers by Peré Domingo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peré Domingo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peré Domingo. The network helps show where Peré Domingo may publish in the future.

Co-authorship network of co-authors of Peré Domingo

This figure shows the co-authorship network connecting the top 25 collaborators of Peré Domingo. A scholar is included among the top collaborators of Peré Domingo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peré Domingo. Peré Domingo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Lipodystrophy in HIV: Evolving Challenges and Unresolved Questions 2025 ·International Journal of Molecular Sciences ·Marta Giralt, Peré Domingo, Tania Quesada‐López, Rubén Cereijo, Francesc Villarroya	1
2	Major cardiovascular events after COVID-19 in people with HIV 2024 ·Clinical Microbiology and Infection ·Raquel Martín-Iguacel, (unknown), Andreu Bruguera, Jordi Aceitón, Daniel K. Nomah, Ana González-Cordón, Peré Domingo, Adrián Curran, Arkaitz Imaz, (unknown), Joaquim Peraire, (unknown), (unknown), Işık Somuncu Johansen, José M Miró, Jordi Casabona, Josep M. Llibre	1
3	Evolving AIDS- and non-AIDS Mortality and Predictors in the PISCIS Cohort of People Living With HIV in Catalonia and the Balearic Islands (Spain), 1998–2020 2024 ·Open Forum Infectious Diseases ·Daniel K. Nomah, (unknown), Andreu Bruguera, (unknown), Yesika Díaz, Lucía Alonso, Jordi Aceitón, Josep M. Llibre, Peré Domingo, María Saumoy, Francisco Homar, Francisco Fanjul, Jordi Navarro, Lorena de la Mora, Hernando Knobel, (unknown), Raquel Martín-Iguacel, José M Miró, Jordi Casabona, Juliana Reyes‐Urueña	4
4	CD66b⁺/CD68⁺ circulating extracellular vesicles, lactate dehydrogenase and neutrophil‐to‐lymphocyte ratio can differentiate coronavirus disease 2019 severity during and after infection 2024 ·Journal of Extracellular Vesicles ·Rosa Suades, Maria Francesca Greco, Paula Prieto, Teresa Padró, Yvan Devaux, Peré Domingo, Lina Badimón	4
5	Decay of HIV RNA in Seminal Plasma and Rectal Fluid in Treatment-Naive Adults Starting Antiretroviral Therapy With Dolutegravir Plus Lamivudine or Bictegravir/Emtricitabine/Tenofovir Alafenamide 2023 ·The Journal of Infectious Diseases ·(unknown), Jordí Niubó, Peré Domingo, (unknown), Adrián Curran, Vicens Díaz-Brito, Judith Peñafiel, Juan Tiraboschi, Sandra Morenilla, Benito García, (unknown), Daniel Podzamczer, Arkaitz Imaz	0
6	Mpox: Clinical Outcomes and Impact of Vaccination in People with and without HIV: A Population-Wide Study 2023 ·Microorganisms ·Raquel Martín-Iguacel, (unknown), Andreu Bruguera, (unknown), (unknown), Yesika Díaz, Lucía Alonso, Daniel K. Nomah, José Luís Blanco, Peré Domingo, (unknown), (unknown), (unknown), (unknown), Sonia Calzado Isbert, Işık Somuncu Johansen, José M. Miró, Jordi Casabona, Josep M. Llibre	5
7	Who is lost to follow‐up in HIV care? Assessment of care retention over time and the impact of COVID‐19. Longitudinal analysis of the PISCIS cohort 2023 ·HIV Medicine ·Jorge Palacio‐Vieira, (unknown), Yesika Díaz, Jordi Aceitón, Andreu Bruguera, Daniel K. Nomah, Josep M. Llibre, Hernando Knobel, Iván Chivite, José M Miró, Peré Domingo, Paula Suanzes, Francisco Fanjul, Gemma Navarro, (unknown), (unknown), Jordi Casabona, Arkaitz Imaz, Juliana Reyes‐Urueña, (unknown)	4
8	Acute Bacterial Meningitis in Healthy Adult Patients: A Prospective Cohort Study 2023 ·Journal of Clinical Medicine ·Virginia Pomar, Natividad Benito, (unknown), (unknown), Alba Rivera, Peré Domingo	0
9	Exposure to valproic acid is associated with less pulmonary infiltrates and improvements in diverse clinical outcomes and laboratory parameters in patients hospitalized with COVID-19 2022 ·PLoS ONE ·Julio Collazos, Peré Domingo, (unknown), (unknown), (unknown), Antonio Lalueza, Emilia Roy‐Vallejo, (unknown), (unknown), Jaime Sanz‐Cánovas, Arturo Artero, José Manuel Ramos, (unknown), (unknown), Víctor Asensi, (unknown)	5
10	Growth Differentiation Factor 15 (GDF-15): A Novel Biomarker Associated with Poorer Respiratory Function in COVID-19 2021 ·Diagnostics ·(unknown), Patricia Peñacoba, (unknown), Diego Castillo, Esther Ortiz Martínez, Laura Martínez‐Martínez, Esther Moga, Peré Domingo, I. Castellví, C. Juárez, (unknown)	17
11	Standardized Comparison of Cardiovascular Risk Factors Prevalence in Spanish Women and Men Living with HIV and in the General Population 2021 ·Journal of Personalized Medicine ·Anna Camps, Sílvia Pérez-Fernández, Isaac Subirana, Ramón Teira, Vicente Estrada, Peré Domingo, Irene R. Dégano, Jaume Marrugat	6
12	Alpha variant SARS-CoV-2 infection: How it all starts 2021 ·EBioMedicine ·Peré Domingo, Natividad Benito	15
13	The pharmacological management of cardiovascular disease in people living with HIV (PLWH) 2020 ·Expert Opinion on Pharmacotherapy ·(unknown), Isabel Mur, (unknown), Francesc Vidal, Peré Domingo	2
14	Discontinuation of dolutegravir, elvitegravir/cobicistat and raltegravir because of toxicity in a prospective cohort 2019 ·HIV Medicine ·Josep M. Llibre, Alexandra Montoliu, JM Miró, Peré Domingo, Melchor Riera, Juan Tiraboschi, Adrián Curran, Francisco Homar, Juan Ambrosioni, (unknown), Lluís Force, Joaquim Peraire, Jordi Casabona, (unknown)	25
15	Renal tubular transporter-mediated interactions of HIV drugs: implications for patient management. 2015 ·PubMed ·Félix Gutiérrez, Xavier Fulladosa, Guillermina Barril, Peré Domingo	43
16	Effect of Baseline Characteristics on the Efficacy and Safety of Once-Daily Darunavir/ Ritonavir in HIV-1–Infected, Treatment-Naïve ARTEMIS Patients at Week 96 2011 ·HIV Clinical Trials ·Jan Fourie, Jason Flamm, (unknown), (unknown), Peré Domingo, Adriano Lazzarin, Juan Ballesteros, Néstor Sosa, Tom Van de Casteele, Ralph DeMasi, Sabrina Spinosa‐Guzman, Ludo Lavreys	9
17	Methicillin-Resistant Staphylococcus aureus Meningitis in Adults 2011 ·Medicine ·Vicente Pintado, (unknown), Jiménez-Mejías Me, Azucena Rodríguez-Guardado, (unknown), Juan Manuel García-Lechuz, Carmen Cabellos, Fernando Cháves, Peré Domingo, António Ramos, (unknown), Diego Domingo	24
18	Targeting only reverse transcriptase with zidovudine/lamivudine/abacavir plus tenofovir in HIV‐1‐infected patients with multidrug‐resistant virus: a multicentre pilot study 2008 ·HIV Medicine ·Josep M. Llibre, Anna Bonjoch, (unknown), (unknown), Eugènia Negredo, Peré Domingo, Núria Pérez‐Álvarez, Javier Martínez‐Picado, Jonathan Schapiro, Bonaventura Clotet, (unknown)	11
19	Failure of Cetirizine to Prevent Nevirapine-Associated Rash 2004 ·JAIDS Journal of Acquired Immune Deficiency Syndromes ·Hernando Knobel, José M. Miró, Beatriz Mahíllo, Peré Domingo, Antonio Rivero, Esteban Ribera, Juan Carlos Montejo González, José Sanz, Alicia González, José Luís Blanco, Vicente Boix, Luís Force, Josep M. Llibre, David Dalmau, Juan Antonio Arroyo, (unknown), Dolors Rodríguez-Pardo, Marisa Montes, Alberto Arranz, (unknown)	14
20	Improvement of dyslipidemia in patients switching from stavudine to tenofovir 2004 ·AIDS ·Peré Domingo, Pablo Labarga, Rosario Palacios, Manuel Fernández Guerrero, (unknown), (unknown), Jesús Santos, (unknown), Josep M. Llibre, Santiago Moreno	41

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact